Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies
长期使用获批用于治疗肥胖症的最高剂量利拉鲁肽可增强与食物线索相关的眶额皮质奖赏激活：这对肥胖症治疗后体重减轻停滞不前具有重要意义
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.13827
Farr, Olivia M; Upadhyay, Jagriti; Rutagengwa, Chelsea; DiPrisco, Bridget; Ranta, Zachary; Adra, Amal; Bapatla, Neha; Douglas, Vivian P; Douglas, Konstantinos A A; Nolen-Doerr, Eric; Mathew, Hannah; Mantzoros, Christos S
